CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 8,605	$ 12,694
Short-term investments	168	498
Accounts receivable (net of allowance for doubtful accounts of $85 in 2023 and $72 in 2022)	10,394	9,450
Inventories (excludes inventories of $3,151 in 2023 and $2,938 in 2022 classified in Other assets - see Note 7)	6,131	5,911
Other current assets	6,656	7,169
Total current assets	31,954	35,722
Investments	1,306	1,015
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,446 in 2023 and $17,985 in 2022	22,526	21,422
Goodwill	21,183	21,204
Other Intangibles, Net	19,199	20,269
Other Assets	10,559	9,528
Total Assets	106,727	109,160
Current Liabilities
Loans payable and current portion of long-term debt	887	1,946
Trade accounts payable	3,509	4,264
Accrued and other current liabilities	14,840	14,159
Income taxes payable	1,981	1,986
Dividends payable	1,877	1,884
Total current liabilities	23,094	24,239
Long-Term Debt	33,972	28,745
Deferred Income Taxes	1,018	1,795
Other Noncurrent Liabilities	7,343	8,323
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022	1,788	1,788
Other paid-in capital	44,358	44,379
Retained earnings	57,082	61,081
Accumulated other comprehensive loss	(4,916)	(4,768)
Stockholders' equity before deduction for treasury stock	98,312	102,480
Less treasury stock, at cost: 1,041,809,729 shares in 2023 and 1,039,269,638 shares in 2022	57,066	56,489
Total Merck & Co., Inc. stockholders’ equity	41,246	45,991
Noncontrolling Interests	54	67
Total equity	41,300	46,058
Liabilities and Equity	$ 106,727	$ 109,160